КШИРСАГАР Раджеш (IN),КАДАМ Чхандрашекар (IN),КАМБЛЕ Правин (IN),МУДДА См (IN)
申请号：
RU2012124216/15
公开号：
RU2012124216A
申请日:
2010.11.01
申请国别(地区):
RU
年份:
2013
代理人:
摘要：
1. Topical pharmaceutical composition comprising a pharmaceutically effective amount of a prostaglandin compound and a pharmaceutically effective amount of NSAID and one or more pharmaceutically acceptable excipients for the treatment of glaucoma and ocular gipertenzii.2. Topical pharmaceutical composition of claim 1 wherein the pH of the composition is from 6.8 to 8,8.3. Topical pharmaceutical composition according to claim 1, wherein the viscosity of the composition is from about 2 to about 120 spz.4. Topical pharmaceutical composition according to claim 1, wherein the composition is packed in LDPE konteyner.5. A method for treating glaucoma and ocular hypertension by administration of the composition p.1.6. Topical ophthalmic composition comprising a pharmaceutically effective amount of travoprost or a pharmaceutically acceptable salt thereof and a pharmaceutically effective amount of the bromfenac or its pharmaceutically acceptable salts, and one or more pharmaceutically acceptable excipients for the treatment of glaucoma and ocular gipertenzii.7. Topical Ophthalmic composition according to claim 6 wherein the pH of the composition from 6.8 to 8,8.8. Topical Ophthalmic composition according to claim 6, wherein the viscosity of the composition from about 2 to about 120 spz.9. Topical Ophthalmic composition according to claim 6 wherein the polyethoxylated castor oil is present in the range of from about 2% w / v to about 10% weight / volume kompozitsii.10. A method for treating glaucoma and ocular hypertension by administration of the composition 6.11. Topical ophthalmic composition comprising a pharmaceutically effective to1. Местнодействующая фармацевтическая композиция, содержащая фармацевтически эффективное количество соединения простагландина и фармацевтически эффективное количество NSAID и один или несколько фармацевтически приемлемых наполнителей для лечения глаукомы и глазной гипертензии.2. Местнодействующая фармацевтическая композиция по п.1, где pH компо
